Watchlists Portfolios Alerts Sign in Get started

Menu

LFSC

F/m Emerald Life Sciences Innovation ETF

USD

Set alert

43.60 USD -1.00 -2.25%

As of Oct 30, 2026 Extended hours 43.60 0.00%

Bid: 43.74 × 2
Ask: 43.97 × 2

43.26 Day range 43.65

31.32 52-week range 48.44

YTD: +19.05%
1 year: +35.44%

Open: 43.65
Prev close: 44.60
Mkt cap: 124.87M
Vol: 1.89K
Avg vol: 3.37K
EPS: 0.00
P/E: 0.00
Div yield: 0.00%

More statistics

Low: 43.26
High: 43.65
Forward P/E: 0.00
Beta: 0.00
Dividend: 0.00
Ex-div date
50-d avg: 25.58
200-d avg: 25.58

Chart tools

Interval

Chart is warming up

The five-day price history for LFSC has not been loaded yet. Try again in a moment.

News

9 months ago benzinga.com

Travere Stock Slips After FDA Delays Review Of Key Kidney Drug

Travere Therapeutics' stock declines as FDA extends review of key kidney drug. Q4 sales forecast at $127 million.
1 year ago seekingalpha.com

LFSC: A New Small-Cap Health Care ETF Prioritizing Innovation Before Profits

LFSC is a relatively new actively managed small-cap health care ETF with $49 million in assets under management and a 0.54% expense ratio after waivers. Although LFSC launched just five months ago,…